Recommendations for including multiple symptoms as endpoints in cancer clinical trials: a report from the ASCPRO (Assessing the Symptoms of Cancer Using Patient-Reported Outcomes) Multisymptom Task Force. (Q43923570)

From Wikidata

Jump to navigation Jump to search

scientific article published on 28 August 2012

Language	Label	Description	Also known as
English	Recommendations for including multiple symptoms as endpoints in cancer clinical trials: a report from the ASCPRO (Assessing the Symptoms of Cancer Using Patient-Reported Outcomes) Multisymptom Task Force.	scientific article published on 28 August 2012

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22930243%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Recommendations for including multiple symptoms as endpoints in cancer clinical trials: a report from the ASCPRO (Assessing the Symptoms of Cancer Using Patient-Reported Outcomes) Multisymptom Task Force (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22930243%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference

based on heuristic

inferred from title

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22930243%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Jeanie F Woodruff

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22930243%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Charles S Cleeland

1

object named as

Charles S Cleeland

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22930243%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

author name string

Jeff A Sloan

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22930243%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Connie Chen

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22930243%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Nora A Janjan

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22930243%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Astra M Liepa

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22930243%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Rajiv Mallick

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22930243%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Ann O'Mara

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22930243%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Jay D Pearson

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22930243%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Yasuhiro Torigoe

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22930243%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Xin Shelley Wang

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22930243%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Loretta A Williams

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22930243%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

CPRO (Assessing the Symptoms of Cancer Using Patient-Reported Outcomes) Multisymptom Task Force

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22930243%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

David Cella

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22930243%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

language of work or name

0 references

publication date

28 August 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22930243%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

number of pages

10

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22930243%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

119

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22930243%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22930243%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

411-420

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22930243%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27744

21 January 2018

Assessing tumor-related signs and symptoms to support cancer drug approval

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27744

21 January 2018

Issues and challenges with integrating patient-reported outcomes in clinical trials supported by the National Cancer Institute-sponsored clinical trials networks

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27744

21 January 2018

Use of patient-reported outcomes in phase III cancer treatment trials: lessons learned and future directions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27744

21 January 2018

Assessing the Symptoms of Cancer Using Patient-Reported Outcomes (ASCPRO): searching for standards

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27744

21 January 2018

ASCPRO recommendations for the assessment of fatigue as an outcome in clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27744

21 January 2018

Quality of life in patients with metastatic renal cell carcinoma treated with sunitinib or interferon alfa: results from a phase III randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27744

21 January 2018

Beyond traditional outcomes: improving quality of life in patients with renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27744

21 January 2018

Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus-associated Kaposi sarcoma: evidence of symptom palliation from chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27744

21 January 2018

Improved quality of life outcomes after laparoscopy-assisted distal gastrectomy for early gastric cancer: results of a prospective randomized clinical trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27744

21 January 2018

The effect of chemotherapy on symptom control and quality of life in patients with advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27744

21 January 2018

The missing voice of patients in drug-safety reporting

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27744

21 January 2018

Patient reported outcomes: looking beyond the label claim

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27744

21 January 2018

Evaluation of the value of attribution in the interpretation of adverse event data: a North Central Cancer Treatment Group and American College of Surgeons Oncology Group investigation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27744

21 January 2018

Cancer symptom assessment instruments: a systematic review

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27744

21 January 2018

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27744

21 January 2018

The Functional Assessment of Cancer Therapy scale: development and validation of the general measure

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27744

21 January 2018

The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27744

21 January 2018

Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27744

21 January 2018

Measuring the symptom burden of lung cancer: the validity and utility of the lung cancer module of the M. D. Anderson Symptom Inventory

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27744

21 January 2018

Priority symptoms in advanced breast cancer: development and initial validation of the National Comprehensive Cancer Network-Functional Assessment of Cancer Therapy-Breast Cancer Symptom Index (NFBSI-16).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27744

21 January 2018

Development and validation of 11 symptom indexes to evaluate response to chemotherapy for advanced cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27744

21 January 2018

Use of existing patient-reported outcome (PRO) instruments and their modification: the ISPOR Good Research Practices for Evaluating and Documenting Content Validity for the Use of Existing Instruments and Their Modification PRO Task Force Report

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27744

21 January 2018

What Are the Most Important Symptom Targets When Treating Advanced Cancer? A Survey of Providers in the National Comprehensive Cancer Network (NCCN)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27744

21 January 2018

Quality measures for supportive cancer care: the Cancer Quality-ASSIST Project

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27744

21 January 2018

Symptom burden and performance status in a population-based cohort of ambulatory cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27744

21 January 2018

Prevalence and aetiology of neuropathic pain in cancer patients: a systematic review

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27744

21 January 2018

The Symptom Cluster of Sleep, Fatigue and Depressive Symptoms in Breast Cancer Patients: Severity of the Problem and Treatment Options

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27744

21 January 2018

Examining the relationships among health-related quality-of-life indicators in cancer patients participating in clinical trials: a pooled study of baseline EORTC QLQ-C30 data

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27744

21 January 2018

Impact of cultural and linguistic factors on symptom reporting by patients with cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27744

21 January 2018

Levels of symptom burden during chemotherapy for advanced lung cancer: differences between public hospitals and a tertiary cancer center.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27744

21 January 2018

Fatigue, dyspnea, and cough comprise a persistent symptom cluster up to five years after diagnosis with lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27744

21 January 2018

Quality of life instruments in oncology

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27744

21 January 2018

Multivariate methods to identify cancer-related symptom clusters

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27744

21 January 2018

Age and gender differences in symptom intensity and symptom clusters among patients with metastatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27744

21 January 2018

Changes in symptom clusters in patients undergoing radiation therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27744

21 January 2018

Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27744

21 January 2018

The value of a symptom cluster of fatigue, dyspnea, and cough in predicting clinical outcomes in lung cancer survivors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27744

21 January 2018

Evaluating the serial use of the Myelofibrosis Symptom Assessment Form for measuring symptomatic improvement: performance in 87 myelofibrosis patients on a JAK1 and JAK2 inhibitor (INCB018424) clinical trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27744

21 January 2018

Q-TWiST analysis of ixabepilone in combination with capecitabine on quality of life in patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27744

21 January 2018

Normative data and trends in quality of life from the Lung Cancer Symptom Scale (LCSS).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27744

21 January 2018

Quality-of-life considerations in patients with advanced lung cancer: effect of topotecan on symptom palliation and quality of life

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27744

21 January 2018

A simple stratification factor prognostic for survival in advanced cancer: the good/bad/uncertain index

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27744

21 January 2018

Analyzing multiple endpoints in clinical trials of pain treatments: IMMPACT recommendations. Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27744

21 January 2018

Causal variables, indicator variables and measurement scales: an example from quality of life

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27744

7 January 2021

based on heuristic

inferred from DOI database lookup

Challenges in QOL assessment. Overview and introduction

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27744

7 January 2021

based on heuristic

inferred from DOI database lookup

Symptom improvement in lung cancer patients treated with erlotinib: quality of life analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27744

7 January 2021

based on heuristic

inferred from DOI database lookup

Validation and application of a module of the M. D. Anderson Symptom Inventory for measuring multiple symptoms in patients with gastrointestinal cancer (the MDASI-GI)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27744

7 January 2021

based on heuristic

inferred from DOI database lookup

Symptoms and treatment burden associated with cancer treatment: results from a cross-sectional national survey in the U.S.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27744

7 January 2021

based on heuristic

inferred from DOI database lookup

Longitudinal study of the relationship between chemoradiation therapy for non-small-cell lung cancer and patient symptoms

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27744

7 January 2021

based on heuristic

inferred from DOI database lookup

Relationship between symptom change, objective tumor measurements, and performance status during chemotherapy for advanced lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27744

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43923570&oldid=2104418977"